Comparison between Acevector IPO and Indira IVF IPO.
Acevector IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Indira IVF IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Acevector IPO is up to ₹0.00 Cr whereas the issue size of the Indira IVF IPO is up to ₹0.00 Cr. The final issue price of Acevector IPO is and of Indira IVF IPO is .
| Acevector IPO | Indira IVF IPO | |
|---|---|---|
| Face Value | ₹1 per share | |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 0 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 0 shares | 0 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Acevector IPO opens on , while Indira IVF IPO opens on . The closing date of Acevector IPO and Indira IVF IPO is , and , respectively.
Acevector IPO P/E ratio is , as compared to Indira IVF IPO P/E ratio of .
| Acevector IPO | Indira IVF IPO | |||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Acevector Ltd.'s revenue increased by 6% and profit after tax (PAT) dropped by 146% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials ()
| ||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 65.31 | |||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||
| RoNW | -100.25% | |||||||||||||||||||||||||||||||||||||||||||
In the Acevector IPO Retail Individual Investors (RII) are offered 0 shares while in Indira IVF IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Acevector IPO and in Indira IVF IPO.
| Acevector IPO | Indira IVF IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | |
| Market Maker Reservation | 0 shares | |
| QIB | 0 shares | |
| NII | 0 shares | |
| RII | 0 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 0 shares |
Acevector IPO subscribed in total, whereas Indira IVF IPO subscribed .
